BioPharma Credit (LON:BPCR - Get Free Report)'s share price traded up 0.4% during trading on Tuesday . The company traded as high as GBX 0.91 ($0.01) and last traded at GBX 0.91 ($0.01). 394,539 shares changed hands during mid-day trading, a decline of 55% from the average session volume of 878,212 shares. The stock had previously closed at GBX 0.91 ($0.01).
BioPharma Credit Price Performance
The company has a 50 day moving average price of GBX 0.87 and a two-hundred day moving average price of GBX 0.87. The stock has a market cap of £1.07 billion, a PE ratio of 10.25 and a beta of 0.22.
BioPharma Credit Cuts Dividend
The business also recently disclosed a dividend, which was paid on Wednesday, May 7th. Investors of record on Thursday, April 3rd were given a dividend of $0.02 per share. The ex-dividend date of this dividend was Thursday, April 3rd. This represents a yield of 1.99%. BioPharma Credit's dividend payout ratio (DPR) is 7,957.15%.
About BioPharma Credit
(
Get Free Report)
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Featured Articles
Before you consider BioPharma Credit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioPharma Credit wasn't on the list.
While BioPharma Credit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
